Viemed focuses on NASDAQ
By HME News Staff
Updated 8:26 AM CST, Tue December 12, 2023
LAFAYETTE, La. - Viemed Healthcare has received approval from the Toronto Stock Exchange to voluntarily delist its common shares on the TSX, in a move that will allow the company to focus on its listing on the NASDAQ Capital Market. “The company is taking strategic action to enhance market efficiency and optimize our administrative processes by consolidating trading volumes on NASDAQ, as the majority of both outstanding shares and trading volume is currently concentrated in the United States,” said Viemed COO Todd Zehnder. “The delisting from TSX will create a singular focal point and central marketplace for the company’s common shares, contributing to increased long-term liquidity on NASDAQ and increased shareholder value.” Viemed’s common shares will be delisted from TSX effective as of close of markets on Dec. 21, 2023. The common shares will continue to trade on NASDAQ under the symbol “VMD” and, following delisting from TSX, Viemed's shareholders can trade their common shares through their brokers on NASDAQ.
Comments